Asarfi Hospital Ltd vs Suven Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Asarfi Hospital Ltd is ₹ 229.9 as of 17 Jun 10:31 . The P/E Ratio of Asarfi Hospital Ltd changed from 31 on March 2024 to 20 on March 2026 . This represents a CAGR of -13.59% over 3 yearsThe P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Asarfi Hospital Ltd changed from ₹ 128.55 crore on March 2024 to ₹ 333.63 crore on March 2026 . This represents a CAGR of 37.42% over 3 yearsThe Market Cap of Suven Life Sciences Ltd changed from ₹ 896.07 crore on March 2021 to ₹ 3503 crore on March 2026 . This represents a CAGR of 25.51% over 6 years The revenue of Asarfi Hospital Ltd for the Jun '26 is ₹ 48.1 crore as compare to the Mar '26 revenue of ₹ 45.89 crore. This represent the growth of 4.82% The revenue of Suven Life Sciences Ltd for the Jun '26 is ₹ 11.09 crore as compare to the Mar '26 revenue of ₹ 8.3 crore. This represent the growth of 33.61% The ebitda of Asarfi Hospital Ltd for the Jun '26 is ₹ 10.02 crore as compare to the Mar '26 ebitda of ₹ 8.36 crore. This represent the growth of 19.86% The ebitda of Suven Life Sciences Ltd for the Jun '26 is ₹ -124 crore as compare to the Mar '26 ebitda of ₹ -43.86 crore. This represent the growth of 184.95% The net profit of Asarfi Hospital Ltd changed from ₹ 1.45 crore to ₹ 4.27 crore over 9 quarters. This represents a CAGR of 61.61% The net profit of Suven Life Sciences Ltd changed from ₹ -28.04 crore to ₹ -127 crore over 9 quarters. This represents a CAGR of 96.11% The Dividend Payout of Asarfi Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Asarfi Hospital Ltd

Asarfi Hospital Limited was originally incorporated as Private Limited Company in the name of 'Asarfi Hospital Private Limited' on October 4, 2005 issued by Registrar of Companies, Bihar & Jharkhand.
Subsequently, status of the Company was converted into Public Limited and name of the Company was changed to 'Asarfi Hospital Limited' vide a fresh Certificate of Incorporation dated February 08, 2012 issued by Registrar of Companies, Jharkhand. Asarfi Ltd is a 250 bedded Multi Speciality Hospital, which is serving people for more than one and half decade by providing healthcare services in Dhanbad, Jharkhand.
Accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL Accredited).
The Company is an integrated healthcare service provider, committed to deliver quality healthcare services to their patients in modern facilities that includes prevention, best treatment and proper rehabilitation.

About Suven Life Sciences Ltd

Suven Life Sciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated in March, 1989.
The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
Promoted by Venkateswarlu Jasti, Company began its operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

FAQs for the comparison of Asarfi Hospital Ltd and Suven Life Sciences Ltd

Which company has a larger market capitalization, Asarfi Hospital Ltd or Suven Life Sciences Ltd?

Market cap of Asarfi Hospital Ltd is 334 Cr while Market cap of Suven Life Sciences Ltd is 7,397 Cr

What are the key factors driving the stock performance of Asarfi Hospital Ltd and Suven Life Sciences Ltd?

The stock performance of Asarfi Hospital Ltd and Suven Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Asarfi Hospital Ltd and Suven Life Sciences Ltd?

As of October 24, 2026, the Asarfi Hospital Ltd stock price is INR ₹170.1. On the other hand, Suven Life Sciences Ltd stock price is INR ₹261.8.

How do dividend payouts of Asarfi Hospital Ltd and Suven Life Sciences Ltd compare?

To compare the dividend payouts of Asarfi Hospital Ltd and Suven Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.